These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 11845567

  • 1. [Initiating insulin therapy in patients with diabetes mellitus type 2: in a transmural setting is at least as effective as in an outpatient setting; a retrospective study with a 4-year follow-up].
    Rosendal H, Vondeling H, de Witte LP, Hutubessy RC, van Beekum WT, Heine RJ.
    Ned Tijdschr Geneeskd; 2002 Jan 26; 146(4):166-71. PubMed ID: 11845567
    [Abstract] [Full Text] [Related]

  • 2. Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group.
    Schiel R, Müller UA, Rauchfub J, Sprott H, Müller R.
    Diabetes Metab; 1999 Sep 26; 25(4):334-40. PubMed ID: 10566123
    [Abstract] [Full Text] [Related]

  • 3. Type 2 diabetes in primary care in belgium: need for structured shared care.
    Goderis G, Borgermans L, Heyrman J, Broeke CV, Grol R, Boland B, Mathieu C.
    Exp Clin Endocrinol Diabetes; 2009 Sep 26; 117(8):367-72. PubMed ID: 19358093
    [Abstract] [Full Text] [Related]

  • 4. [Differences between diabetes mellitus type 2 patients switched and not switched over to insulin treatment after specialist consultation].
    Goddijn PP, Meyboom-de Jong B, Feskens EJ, van Ballegooie E, Bilo HJ.
    Ned Tijdschr Geneeskd; 1998 May 02; 142(18):1023-6. PubMed ID: 9623204
    [Abstract] [Full Text] [Related]

  • 5. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel.
    Curr Med Res Opin; 2009 Nov 02; 25(11):2643-54. PubMed ID: 19751116
    [Abstract] [Full Text] [Related]

  • 6. Quality of care for patients with type 2 diabetes mellitus in the Netherlands and the United States: a comparison of two quality improvement programs.
    Valk GD, Renders CM, Kriegsman DM, Newton KM, Twisk JW, van Eijk JT, van der Wal G, Wagner EH.
    Health Serv Res; 2004 Aug 02; 39(4 Pt 1):709-25. PubMed ID: 15230924
    [Abstract] [Full Text] [Related]

  • 7. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS, McLaughlin T, Loza L, Beauchamp R, Schwartz S, Kipnes M.
    Curr Med Res Opin; 2004 Nov 02; 20(11):1703-10. PubMed ID: 15537471
    [Abstract] [Full Text] [Related]

  • 8. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
    Meneghini L, Koenen C, Weng W, Selam JL.
    Diabetes Obes Metab; 2007 Nov 02; 9(6):902-13. PubMed ID: 17924873
    [Abstract] [Full Text] [Related]

  • 9. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.
    Clin Ther; 2007 Jun 02; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [Abstract] [Full Text] [Related]

  • 10. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A, Sämann A, Kubiak T, Zieschang T, Kloos C, Müller UA, Oster P, Wolf G, Schiel R.
    Patient Educ Couns; 2008 Oct 02; 73(1):50-9. PubMed ID: 18583087
    [Abstract] [Full Text] [Related]

  • 11. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
    Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y, IMPROVE Study Group Expert Panel.
    Int J Clin Pract; 2009 Mar 02; 63(3):522-31. PubMed ID: 19187170
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
    Dornhorst A, Lüddeke HJ, Sreenan S, Koenen C, Hansen JB, Tsur A, Landstedt-Hallin L.
    Int J Clin Pract; 2007 Mar 02; 61(3):523-8. PubMed ID: 17313628
    [Abstract] [Full Text] [Related]

  • 13. Should insulin therapy in type 2 diabetic patients be started on an out- or inpatient basis? Results of a prospective controlled trial using the same treatment and teaching programme in ambulatory care and a university hospital.
    Müller UA, Müller R, Starrach A, Hunger-Dathe W, Schiel R, Jörgens V, Grüsser M.
    Diabetes Metab; 1998 Jun 02; 24(3):251-5. PubMed ID: 9690059
    [Abstract] [Full Text] [Related]

  • 14. Initiating insulin treatment in insulin-requiring type 2 diabetic patients: comparative efficiency and cost of outpatient and inpatient management. INNOV Study Group.
    Penfornis A, Millot L.
    Diabetes Metab; 1998 Apr 02; 24(2):137-42. PubMed ID: 9592638
    [Abstract] [Full Text] [Related]

  • 15. Weight gain in type 2 diabetes mellitus--not all uphill.
    Cohen O, Norymberg C, Neumann E, Dekel H.
    Diabetes Res Clin Pract; 2008 Jan 02; 79(1):128-32. PubMed ID: 17720273
    [Abstract] [Full Text] [Related]

  • 16. Long-term efficacy of steady-dose metformin in type 2 diabetes mellitus: a retrospective study.
    Drzewoski J, Czupryniak L.
    Med Sci Monit; 2003 Jun 02; 9(6):CR240-3. PubMed ID: 12824953
    [Abstract] [Full Text] [Related]

  • 17. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.
    Rajagopalan R, Rosenson RS, Fernandes AW, Khan M, Murray FT.
    Clin Ther; 2004 Sep 02; 26(9):1400-10. PubMed ID: 15531002
    [Abstract] [Full Text] [Related]

  • 18. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.
    Khutsoane D, Sharma SK, Almustafa M, Jang HC, Azar ST, Danciulescu R, Shestakova M, Ayad NM, Guler S, Bech OM, PRESENT Study Group.
    Diabetes Obes Metab; 2008 Mar 02; 10(3):212-22. PubMed ID: 18269636
    [Abstract] [Full Text] [Related]

  • 19. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes.
    Donnelly LA, Morris AD, Evans JM, DARTS/MEMO collaboration.
    QJM; 2007 Jun 02; 100(6):345-50. PubMed ID: 17504861
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB, Fonseca VA, Truitt KE, Jones MR.
    Arch Intern Med; 2008 Jul 28; 168(14):1531-40. PubMed ID: 18663165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.